Treatment of age related macular degeneration (AMD) currently and in the past
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. AMD causes no pain. AMD is an irreparable disorder...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2018-08-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5860 |
id |
doaj-ad324b09e80a4497a21131742dbe3aad |
---|---|
record_format |
Article |
spelling |
doaj-ad324b09e80a4497a21131742dbe3aad2020-11-24T23:48:47ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062018-08-018885086110.5281/zenodo.14030115371Treatment of age related macular degeneration (AMD) currently and in the pastKlaudia Brożyna0Jędrzej Tkaczyk1Katarzyna Baltaziak2Krystian Ciechański3Lucyna Baltaziak4Robert Rejdak5Medical University of LublinStudent`s Research Group at the Department of Epidemiology and Clinical Research Methodology, Medical University of LublinStudent`s Research Group at the Clinical Department of Ophthalmology, Medical University of LublinStudent`s Research Group at the Department of Epidemiology and Clinical Research Methodology, Medical University of LublinMedical University of LublinClinical Department of General Ophthalmology, Medical University of LublinAge-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. AMD causes no pain. AMD is an irreparable disorder, which mostly occurs among people after 50. Nowadays the pathogenesis of AMD is still not entirely clarified, however this disorder has multifactor background, which include interactions between genetic and environmental factors. AMD is divided into two forms: exudative (“wet”) and nonexudative (“dry”). The treatment of age-related macular degeneration depends on the stage of the disease progression. One of the first methods of treatment of exudative AMD was laser photocoagulation with argon laser. Currently, this kind of treatment is used in certain cases of neovascularization in extrafoveal area. Next elderly method of therapy of AMD was a photodynamic therapy (PDT) at year 2000. The treatment consist in intravenous injection of verteporfin and a laser at the same time. At 2002 was in use transpupillary thermotherapy (TTT). Last few years for treatment AMD is used antagonist of vascular endothelial growth factor (VEGF). We distinguish: pegatanib, ranibizumab, bevacizumab and aflibercept. Nowadays all of available methods do not eliminate causes of that disorder and in this connection currently treatment is still symptomatic. Apart from every mentioned method above, nutritional therapy is also essential and it decrease the risk of progression of AMD. The diet should contain products full of vitamin C,E, beta carotene, zinc and copper.http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5860amd, treatment, pathogenesis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Klaudia Brożyna Jędrzej Tkaczyk Katarzyna Baltaziak Krystian Ciechański Lucyna Baltaziak Robert Rejdak |
spellingShingle |
Klaudia Brożyna Jędrzej Tkaczyk Katarzyna Baltaziak Krystian Ciechański Lucyna Baltaziak Robert Rejdak Treatment of age related macular degeneration (AMD) currently and in the past Journal of Education, Health and Sport amd, treatment, pathogenesis |
author_facet |
Klaudia Brożyna Jędrzej Tkaczyk Katarzyna Baltaziak Krystian Ciechański Lucyna Baltaziak Robert Rejdak |
author_sort |
Klaudia Brożyna |
title |
Treatment of age related macular degeneration (AMD) currently and in the past |
title_short |
Treatment of age related macular degeneration (AMD) currently and in the past |
title_full |
Treatment of age related macular degeneration (AMD) currently and in the past |
title_fullStr |
Treatment of age related macular degeneration (AMD) currently and in the past |
title_full_unstemmed |
Treatment of age related macular degeneration (AMD) currently and in the past |
title_sort |
treatment of age related macular degeneration (amd) currently and in the past |
publisher |
Kazimierz Wielki University |
series |
Journal of Education, Health and Sport |
issn |
2391-8306 |
publishDate |
2018-08-01 |
description |
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail. AMD causes no pain.
AMD is an irreparable disorder, which mostly occurs among people after 50. Nowadays the pathogenesis of AMD is still not entirely clarified, however this disorder has multifactor background, which include interactions between genetic and environmental factors. AMD is divided into two forms: exudative (“wet”) and nonexudative (“dry”). The treatment of age-related macular degeneration depends on the stage of the disease progression. One of the first methods of treatment of exudative AMD was laser photocoagulation with argon laser. Currently, this kind of treatment is used in certain cases of neovascularization in extrafoveal area. Next elderly method of therapy of AMD was a photodynamic therapy (PDT) at year 2000. The treatment consist in intravenous injection of verteporfin and a laser at the same time. At 2002 was in use transpupillary thermotherapy (TTT).
Last few years for treatment AMD is used antagonist of vascular endothelial growth factor (VEGF). We distinguish: pegatanib, ranibizumab, bevacizumab and aflibercept. Nowadays all of available methods do not eliminate causes of that disorder and in this connection currently treatment is still symptomatic. Apart from every mentioned method above, nutritional therapy is also essential and it decrease the risk of progression of AMD. The diet should contain products full of vitamin C,E, beta carotene, zinc and copper. |
topic |
amd, treatment, pathogenesis |
url |
http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5860 |
work_keys_str_mv |
AT klaudiabrozyna treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast AT jedrzejtkaczyk treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast AT katarzynabaltaziak treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast AT krystianciechanski treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast AT lucynabaltaziak treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast AT robertrejdak treatmentofagerelatedmaculardegenerationamdcurrentlyandinthepast |
_version_ |
1725484558253555712 |